V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240000984 | 240011989 | 1.67 | 125.5 | null | null | 2022-03-25 | Rituximab | N | null | RITUXIMAB | 101342003 |
| 240001095 | 240011991 | 1.64 | 150 | null | null | 2021-03-02 | null | N | null | TRASTUZUMAB | 101404275 |
| 240001153 | 240011992 | 1.76 | 56.8 | null | null | 2021-04-04 | null | 01 | null | AML RELAPSED FLA | 100890892 |
| 240002171 | 240011996 | 1.52 | 73.2 | Palliative (P) | 2022-02-03 | 2022-02-04 | null | 02 | N | RUXOLITINIB | 101783614 |
| 240002241 | 240011997 | 1.84 | 76 | null | 2021-04-29 | 2021-04-29 | Cytarabine High Dose | N | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100540022 |
| 240002374 | 240011999 | 1.65 | 53.9 | null | 2020-10-05 | 2020-10-08 | Cladribine (subcut) 5 days | 02 | null | ALL UKALL2011 DEL INT A | 100187681 |
| 240002489 | 240012002 | 1.65 | 59.6 | Palliative (P) | 2022-01-04 | 2022-03-02 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101869442 |
| 240000501 | 240012010 | null | null | null | null | 2016-09-10 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100485686 |
| 240000787 | 240012019 | null | null | null | null | 2018-10-24 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100335001 |
| 240000793 | 240012021 | null | null | Curative (C) | null | 2017-11-03 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101264579 |
| 240000866 | 240012027 | 1.8 | 21.35 | null | 2017-12-14 | 2017-12-16 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101710075 |
| 240000868 | 240012028 | 1.55 | 56.9 | null | 2020-02-29 | 2020-03-07 | Rituximab | 02 | N | RITUXIMAB | 101726716 |
| 240000876 | 240012029 | 0 | 79 | null | null | 2019-02-01 | null | null | null | METHOTREXATE | 101306403 |
| 240000890 | 240012031 | null | null | null | 2018-05-09 | 2018-05-14 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101202013 |
| 240000899 | 240012032 | 0 | 87.5 | 03 | null | 2019-06-15 | null | null | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101010158 |
| 240000914 | 240012036 | null | 70.8 | Palliative (P) | null | 2018-12-31 | null | null | N | CHLORAMBUCIL + OBINUTUZUMAB | 100619343 |
| 240000922 | 240012037 | null | 66.9 | null | null | null | FLAG + Idarubicin | null | null | CYTARABINE HIGH DOSE | 100060122 |
| 240000998 | 240012039 | 1.63 | 63 | null | null | 2017-01-22 | AZACITIDINE + VENETOCLAX | null | N | VENETOCLAX | 101189260 |
| 240001095 | 240012040 | 1.78 | 77.6 | Palliative (P) | null | 2021-02-23 | null | null | N | MELPHALAN | 101404275 |
| 240002287 | 240012046 | 1.62 | 68.5 | Curative (C) | 2019-12-25 | 2020-03-13 | NHL 2003 Gp B COP | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101567333 |
| 240002374 | 240012047 | 1.5 | 77.1 | null | 2021-01-15 | 2021-01-31 | ALL UKALL2011 Maintenance A2 | 01 | N | ANAGRELIDE | 100187681 |
| 240002391 | 240012048 | 0 | 76 | null | 2021-07-15 | 2021-07-30 | CVP R | 02 | null | PILOT TRIAL | 101179262 |
| 240002722 | 240012051 | 1.6 | 89.1 | Disease modification (D) | 2021-01-22 | 2021-03-11 | PEG INTERFERON | N | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100415407 |
| 240000533 | 240012054 | 1.43 | 67.8 | Curative (C) | null | 2020-01-22 | null | 02 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 100823555 |
| 240000876 | 240012071 | 1.49 | 60 | null | null | 2019-02-09 | null | 02 | null | AZACITIDINE | 101306403 |
| 240000879 | 240012072 | 1.73 | 89.3 | null | null | 2021-01-16 | null | null | null | AML19 TRIAL | 100414983 |
| 240000899 | 240012073 | 1.87 | 50.9 | 03 | null | 2019-07-05 | null | null | null | METHOTREXATE | 101010158 |
| 240000908 | 240012074 | 1.85 | 47.7 | Palliative (P) | 2020-09-14 | 2020-09-27 | Rituximab | null | N | RITUXIMAB | 101326969 |
| 240000910 | 240012075 | 1.8 | 62.65 | null | null | 2020-01-21 | null | 02 | null | CYTARABINE | 100812971 |
| 240000998 | 240012080 | null | null | null | 2017-04-05 | 2017-04-05 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | METHOTREXATE INTRATHECAL | 101189260 |
| 240001095 | 240012081 | 1.72 | 52.8 | 03 | 2021-03-19 | 2021-03-20 | Cyclophosphamide + Dex + Rituximab | 02 | null | FLAG + IDARUBICIN | 101404275 |
| 240002241 | 240012085 | 1.69 | 95.1 | 03 | 2021-10-30 | 2021-10-30 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | IMATINIB | 100540022 |
| 240002287 | 240012086 | 1.64 | 80.2 | Curative (C) | null | 2020-03-13 | null | null | null | BUSULFAN | 101567333 |
| 240000533 | 240012092 | 0 | 28.1 | null | 2019-12-08 | 2020-02-20 | GEMTUZUMAB OZOGAMICIN | 02 | null | DABRAFENIB | 100823555 |
| 240000899 | 240012108 | null | null | 03 | 2021-12-20 | 2021-12-21 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101010158 |
| 240000910 | 240012109 | 1.78 | 78.6 | 03 | 2020-02-18 | 2020-02-23 | AML 19 TRIAL | null | N | AML19 TRIAL | 100812971 |
| 240000914 | 240012110 | 1.68 | 66.7 | null | 2020-08-05 | 2020-08-11 | AML MyeChild | 02 | null | FLUOROURACIL + OXALIPLATIN | 100619343 |
| 240001095 | 240012114 | 1.85 | 93.8 | Curative (C) | 2021-04-12 | 2021-04-12 | Cytarabine High Dose | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101404275 |
| 240001153 | 240012115 | 1.82 | 67.3 | null | null | 2022-05-20 | Cytarabine High Dose | 02 | N | IBRUTINIB | 100890892 |
| 240002241 | 240012117 | null | 69.6 | Curative (C) | 2021-09-03 | 2021-11-30 | IDELALISIB + RITUXIMAB | 02 | null | INTERFERON ALFA | 100540022 |
| 240002845 | 240012120 | 1.5 | 62 | null | 2020-08-28 | 2020-12-21 | Arsenic trioxide + Tretinoin | N | null | CYCLOPHOSPHAMIDE | 101713235 |
| 240000533 | 240012121 | 1.72 | 79.9 | null | 2020-03-17 | 2020-03-19 | DA 3 + 10 | 02 | null | NOT MATCHED | 100823555 |
| 240000793 | 240012128 | null | null | null | null | 2017-11-03 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101264579 |
| 240000910 | 240012136 | null | null | null | 2020-02-17 | 2020-02-23 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100812971 |
| 240000998 | 240012140 | 0 | 78.7 | Curative (C) | 2018-08-09 | 2018-08-16 | null | 02 | null | GEMCARBO | 101189260 |
| 240001095 | 240012141 | 1.77 | 30.45 | 03 | null | 2021-04-15 | null | null | null | CYTARABINE HIGH DOSE | 101404275 |
| 240002241 | 240012144 | 1.63 | 79 | null | null | 2022-01-06 | Clofarabine + Cytarabine | null | null | CYTARABINE + ETOPOSIDE + IFOSFAMIDE | 100540022 |
| 240000793 | 240012152 | null | null | null | null | 2017-12-21 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101264579 |
| 240000838 | 240012155 | null | null | null | null | 2019-05-23 | null | 02 | null | HYDROXYCARBAMIDE | 101718703 |
| 240000910 | 240012159 | 1.79 | 47.8 | Palliative (P) | null | 2020-05-10 | null | null | N | TRIAL UNSPECIFIED | 100812971 |